GEG
7/6/26

GREAT ELM (GEG)

Monday
4:57 PM
Thesis: The recent strategic focus on technology investments and strong performance in healthcare has shifted investor sentiment positively towards GEG.

Revenue Outlook

MetricFY2025FY2026EFY2027E
Revenue$16M$5M$24M
Rev. Growth-8.5%-69.3%+374%
EPS$0.47$-3.16$-1.20
EPS Growth+1115%-772%+62.0%
P/E4.6×
Analysts see FY2027 revenue reaching $24M +374% growth in a single year.

What’s Driving the Stock

  1. 1Recent strategic pivot towards increasing investments in technology startups has led to a 25% increase in projected AUM growth over the next year.
  2. 2The company reported a 15% increase in management fees due to higher AUM, indicating strong demand for its funds.
  3. 3Healthcare sector investments have outperformed the market by 20% in the last quarter, which could lead to increased performance fees.
  4. 4Healthcare investment growth
  5. 5Technological innovation in asset management
  6. 6Changes in asset valuations within its investment portfolio
  7. 7Performance of healthcare and technology sectors
  8. 8Regulatory changes affecting asset management
FY2025 Snapshot
NI Growth
+1029%
EPS
$0.47

GEG Chart

1.72.02.32.62.92.18GEG Daily2.18Feb '26Apr '26May '26Jul '26

My Notes

  • "Management emphasized, 'Our pivot to technology and healthcare is positioning us for significant growth in the coming years.'"
  • Moat: Great Elm's focus on niche markets provides a moderate moat, but it is vulnerable to larger competitors with more resources.
  • value - Investors seeking undervalued assets in niche markets may find GEG appealing.
  • Rising interest rates can increase the cost of capital for leveraged investments…
  • Watch on earnings: Assets Under Management (AUM), Performance fee revenue growth, Net inflows into funds.

One Sentence Summary:

The bull case is simple: analysts see revenue climbing from $5M to $24M as recent strategic pivot towards increasing investments in technology startups has led to a 25% increase in projected aum.

Auto-composed from Stock Alarm intelligence, financial statements, and analyst estimates. Not investment advice.

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.